Literature DB >> 30174870

Relation between changes in red blood cell distribution width after coronary artery bypass grafting and early postoperative morbidity.

Seok In Lee1, So Young Lee1, Chang Hyu Choi1, Chul-Hyun Park1, Kook Yang Park1, Kuk Hui Son1.   

Abstract

BACKGROUND: Red blood cell distribution width (RDW) is highly associated with various clinical states. In the present study, we aimed to determine the natures of associations between RDW changes and early adverse events after isolated coronary artery bypass grafting (CABG).
METHODS: We retrospectively analyzed medical records of enrolled 117 patients. Patients were classified into two groups depending on early adverse events (No-event vs. Event). Delta RDW values were calculated (ΔRDW: Post-Peak RDW minus Pre-RDW). Patients were divided into tertiles based on ΔRDW. The ΔRDW cut-off point for an adverse event was determined by receiver operating characteristic curve analysis. In addition, logistic regression analysis was performed to identify independent factors of early adverse events.
RESULTS: Thirty eight patients experienced 53 early adverse events. ΔRDW and ΔC-reactive protein were significantly higher in the Events group than in the No-event group. Incidences of early adverse events increased significantly between ΔRDW tertiles (P<0.001). The ROC curve of ΔRDW showed that a ΔRDW of ≥1.45 had a sensitivity of 71.1% and a specificity of 78.2% for predicting an early adverse event after CABG (P<0.001). Multivariable analysis showed ΔRDW (P=0.042) and length of ICU stay (P<0.001) independently predicted an adverse event.
CONCLUSIONS: ΔRDW was identified to be an independent predictor of early adverse events, and a ΔRDW cut-off of 1.45 was found to predict early adverse events after CABG. Careful monitoring of RDW trends after isolated CABG provides a simple, inexpensive and objective means of predicting early adverse events.

Entities:  

Keywords:  Red blood cell distribution width (RDW); complication; coronary artery bypass grafting (CABG)

Year:  2018        PMID: 30174870      PMCID: PMC6106013          DOI: 10.21037/jtd.2018.06.108

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.

Authors:  Vikas Veeranna; Sandip K Zalawadiya; Sidakpal Panaich; Kushang V Patel; Luis Afonso
Journal:  Int J Cardiol       Date:  2013-09-07       Impact factor: 4.164

3.  Red blood cell distribution width predicts mortality after coronary artery bypass grafting.

Authors:  Umberto Benedetto; Emiliano Angeloni; Giovanni Melina; Calogera Pisano; Andrea Lechiancole; Antonino Roscitano; Martin Pooley; Cosimo Comito; Massimiliano Codispoti; Riccardo Sinatra
Journal:  Int J Cardiol       Date:  2012-09-07       Impact factor: 4.164

Review 4.  Red blood cell distribution width and cardiovascular diseases.

Authors:  Elisa Danese; Giuseppe Lippi; Martina Montagnana
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

5.  Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.

Authors:  Jason M Lappé; Benjamin D Horne; Svati H Shah; Heidi T May; Joseph B Muhlestein; Donald L Lappé; Abdallah G Kfoury; John F Carlquist; Deborah Budge; Rami Alharethi; Tami L Bair; William E Kraus; Jeffrey L Anderson
Journal:  Clin Chim Acta       Date:  2011-07-27       Impact factor: 3.786

6.  Red cell distribution width is a prognostic marker of perioperative stroke in patients undergoing cardiac valve surgery.

Authors:  Piotr Duchnowski; Tomasz Hryniewiecki; Mariusz Kusmierczyk; Piotr Szymanski
Journal:  Interact Cardiovasc Thorac Surg       Date:  2017-12-01

7.  Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure.

Authors:  Nay Aung; Hua Zen Ling; Adrian S Cheng; Suneil Aggarwal; Julia Flint; Michelle Mendonca; Mohammed Rashid; Swan Kang; Susanne Weissert; Caroline J Coats; Toby Richards; Martin Thomas; Simon Woldman; Darlington O Okonko
Journal:  Int J Cardiol       Date:  2013-01-22       Impact factor: 4.164

8.  Raised red cell distribution width as a prognostic marker in aortic valve replacement surgery.

Authors:  Piotr Duchnowski; Piotr Szymański; Ewa Orłowska-Baranowska; Mariusz Kuśmierczyk; Tomasz Hryniewiecki
Journal:  Kardiol Pol       Date:  2015-10-27       Impact factor: 3.108

9.  Elevated red blood cell distribution width predicts mortality in persons with known stroke.

Authors:  Chizobam Ani; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2008-11-22       Impact factor: 3.181

Review 10.  The Prognostic Role of Red Blood Cell Distribution Width in Coronary Artery Disease: A Review of the Pathophysiology.

Authors:  Kamil Bujak; Jarosław Wasilewski; Tadeusz Osadnik; Sandra Jonczyk; Aleksandra Kołodziejska; Marek Gierlotka; Mariusz Gąsior
Journal:  Dis Markers       Date:  2015-08-26       Impact factor: 3.434

View more
  2 in total

1.  A retrospective cohort study on the association between elevated preoperative red cell distribution width and all-cause mortality after noncardiac surgery.

Authors:  Halldor B Olafsson; Gissur A Sigurdarson; Kenneth B Christopher; Sigurbergur Karason; Gisli H Sigurdsson; Martin I Sigurdsson
Journal:  Br J Anaesth       Date:  2020-03-23       Impact factor: 9.166

2.  Red Blood Cell Distribution Width Predicts 1-month Complications after Percutaneous Transluminal Angioplasty.

Authors:  Gian Franco Veraldi; Luca Mezzetto; Lorenzo Scorsone; Marco Macrì; Fabio Simoncini; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2019-07-30       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.